Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 68% ± 21% | |
peripheral blood | 19 studies | 42% ± 13% | |
brain | 13 studies | 35% ± 21% | |
intestine | 12 studies | 64% ± 23% | |
eye | 10 studies | 47% ± 21% | |
kidney | 9 studies | 61% ± 17% | |
liver | 7 studies | 39% ± 12% | |
bone marrow | 6 studies | 45% ± 22% | |
pancreas | 5 studies | 79% ± 24% | |
uterus | 5 studies | 83% ± 15% | |
prostate | 5 studies | 65% ± 33% | |
lymph node | 5 studies | 41% ± 30% | |
placenta | 4 studies | 79% ± 30% | |
heart | 4 studies | 41% ± 16% | |
adipose | 4 studies | 54% ± 17% | |
breast | 4 studies | 76% ± 12% | |
ovary | 3 studies | 55% ± 25% | |
adrenal gland | 3 studies | 45% ± 7% | |
esophagus | 3 studies | 64% ± 20% | |
skin | 3 studies | 60% ± 16% | |
thymus | 3 studies | 36% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 32253.86 | 258 / 258 | 100% | 1155.57 | 230 / 230 |
kidney | 100% | 22244.45 | 89 / 89 | 100% | 1130.44 | 901 / 901 |
pancreas | 100% | 17643.51 | 328 / 328 | 100% | 1221.47 | 178 / 178 |
thymus | 100% | 26430.51 | 653 / 653 | 100% | 1473.36 | 605 / 605 |
uterus | 100% | 28982.25 | 170 / 170 | 100% | 845.87 | 457 / 459 |
skin | 100% | 24878.08 | 1800 / 1809 | 100% | 2843.21 | 472 / 472 |
lung | 100% | 34342.72 | 578 / 578 | 99% | 895.78 | 1148 / 1155 |
ovary | 100% | 23055.13 | 180 / 180 | 99% | 586.43 | 427 / 430 |
stomach | 100% | 23119.97 | 359 / 359 | 99% | 609.60 | 284 / 286 |
intestine | 100% | 27669.55 | 966 / 966 | 99% | 745.64 | 520 / 527 |
prostate | 100% | 19984.97 | 244 / 245 | 99% | 781.91 | 497 / 502 |
breast | 100% | 29513.16 | 459 / 459 | 98% | 825.91 | 1101 / 1118 |
bladder | 100% | 28487.90 | 21 / 21 | 98% | 896.44 | 496 / 504 |
esophagus | 100% | 21147.58 | 1444 / 1445 | 91% | 336.68 | 166 / 183 |
brain | 91% | 9870.52 | 2394 / 2642 | 100% | 814.56 | 703 / 705 |
liver | 86% | 9226.27 | 195 / 226 | 100% | 671.48 | 404 / 406 |
adipose | 100% | 35685.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 34448.05 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 2970.28 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 739.28 | 29 / 29 |
spleen | 100% | 21983.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 565.48 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 678.54 | 1 / 1 |
muscle | 100% | 20556.51 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 26963.52 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 21749.85 | 901 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035646 | Biological process | endosome to melanosome transport |
GO_1901379 | Biological process | regulation of potassium ion transmembrane transport |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_1900746 | Biological process | regulation of vascular endothelial growth factor signaling pathway |
GO_2001046 | Biological process | positive regulation of integrin-mediated signaling pathway |
GO_0002092 | Biological process | positive regulation of receptor internalization |
GO_0048757 | Biological process | pigment granule maturation |
GO_0015031 | Biological process | protein transport |
GO_0016477 | Biological process | cell migration |
GO_0005615 | Cellular component | extracellular space |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0031088 | Cellular component | platelet dense granule membrane |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0097487 | Cellular component | multivesicular body, internal vesicle |
GO_0009986 | Cellular component | cell surface |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0010008 | Cellular component | endosome membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0042470 | Cellular component | melanosome |
GO_0031904 | Cellular component | endosome lumen |
GO_0005515 | Molecular function | protein binding |
Gene name | CD63 |
Protein name | CD63 molecule Tetraspanin CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Lysosome integral membrane protein 1) (Limp1) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) (CD antigen CD63) |
Synonyms | MLA1 TSPAN30 |
Description | FUNCTION: Functions as a cell surface receptor for TIMP1 and plays a role in the activation of cellular signaling cascades. Plays a role in the activation of ITGB1 and integrin signaling, leading to the activation of AKT, FAK/PTK2 and MAP kinases. Promotes cell survival, reorganization of the actin cytoskeleton, cell adhesion, spreading and migration, via its role in the activation of AKT and FAK/PTK2. Plays a role in VEGFA signaling via its role in regulating the internalization of KDR/VEGFR2. Plays a role in intracellular vesicular transport processes, and is required for normal trafficking of the PMEL luminal domain that is essential for the development and maturation of melanocytes. Plays a role in the adhesion of leukocytes onto endothelial cells via its role in the regulation of SELP trafficking. May play a role in mast cell degranulation in response to Ms4a2/FceRI stimulation, but not in mast cell degranulation in response to other stimuli. . FUNCTION: Functions as a cell surface receptor for TIMP1 and plays a role in the activation of cellular signaling cascades. Plays a role in the activation of ITGB1 and integrin signaling, leading to the activation of AKT, FAK/PTK2 and MAP kinases. Promotes cell survival, reorganization of the actin cytoskeleton, cell adhesion, spreading and migration, via its role in the activation of AKT and FAK/PTK2. Plays a role in VEGFA signaling via its role in regulating the internalization of KDR/VEGFR2. Plays a role in intracellular vesicular transport processes, and is required for normal trafficking of the PMEL luminal domain that is essential for the development and maturation of melanocytes. Plays a role in the adhesion of leukocytes onto endothelial cells via its role in the regulation of SELP trafficking. May play a role in mast cell degranulation in response to Ms4a2/FceRI stimulation, but not in mast cell degranulation in response to other stimuli. . FUNCTION: Functions as a cell surface receptor for TIMP1 and plays a role in the activation of cellular signaling cascades. Plays a role in the activation of ITGB1 and integrin signaling, leading to the activation of AKT, FAK/PTK2 and MAP kinases. Promotes cell survival, reorganization of the actin cytoskeleton, cell adhesion, spreading and migration, via its role in the activation of AKT and FAK/PTK2. Plays a role in VEGFA signaling via its role in regulating the internalization of KDR/VEGFR2. Plays a role in intracellular vesicular transport processes, and is required for normal trafficking of the PMEL luminal domain that is essential for the development and maturation of melanocytes. Plays a role in the adhesion of leukocytes onto endothelial cells via its role in the regulation of SELP trafficking. May play a role in mast cell degranulation in response to Ms4a2/FceRI stimulation, but not in mast cell degranulation in response to other stimuli. . FUNCTION: Functions as a cell surface receptor for TIMP1 and plays a role in the activation of cellular signaling cascades. Plays a role in the activation of ITGB1 and integrin signaling, leading to the activation of AKT, FAK/PTK2 and MAP kinases. Promotes cell survival, reorganization of the actin cytoskeleton, cell adhesion, spreading and migration, via its role in the activation of AKT and FAK/PTK2. Plays a role in VEGFA signaling via its role in regulating the internalization of KDR/VEGFR2. Plays a role in intracellular vesicular transport processes, and is required for normal trafficking of the PMEL luminal domain that is essential for the development and maturation of melanocytes. Plays a role in the adhesion of leukocytes onto endothelial cells via its role in the regulation of SELP trafficking. May play a role in mast cell degranulation in response to Ms4a2/FceRI stimulation, but not in mast cell degranulation in response to other stimuli. . |
Accessions | P08962 ENST00000546457.1 ENST00000551173.5 ENST00000548898.5 ENST00000549117.5 [P08962-1] ENST00000552754.5 [P08962-2] ENST00000420846.7 [P08962-1] ENST00000550050.5 ENST00000552164.5 F8VX62 ENST00000257857.9 [P08962-1] F8VNT9 W6A4U0 F8W022 ENST00000552067.5 ENST00000548160.5 F8VV56 F8VWK8 ENST00000552692.5 [P08962-1] ENST00000546939.5 [P08962-3] ENST00000550776.5 [P08962-3] |